STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial | MicrobiomeTrials
STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2023-10-15Est. Completion: 2027-02-15
Enrollment target: 2,700 participants
Locations
Fuwai Hospital, National Center for Cardiovascular Diseases，Chinese Academy of Medical Sciences, Beijing, China
Other microbiome trials you might be interested in